CareCloud (CCLD) Expected to Release Quarterly Earnings on Thursday

CareCloud (NASDAQ:CCLD) is expected to be issuing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect CareCloud to post earnings of $0.07 per share and revenue of $31.8510 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:30 AM ET.

CareCloud (NASDAQ:CCLD) last released its earnings results on Thursday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.01). The business had revenue of $31.27 million for the quarter, compared to the consensus estimate of $30.51 million. CareCloud had a return on equity of 24.05% and a net margin of 7.87%. On average, analysts expect CareCloud to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

CareCloud Stock Performance

Shares of NASDAQ:CCLD opened at $2.60 on Wednesday. The company’s 50-day moving average is $2.29 and its 200 day moving average is $2.63. The company has a market capitalization of $110.47 million, a P/E ratio of 23.64 and a beta of 1.51. CareCloud has a fifty-two week low of $2.04 and a fifty-two week high of $4.01.

Hedge Funds Weigh In On CareCloud

Large investors have recently made changes to their positions in the stock. HRT Financial LP bought a new stake in shares of CareCloud during the 4th quarter valued at $43,000. Centiva Capital LP bought a new position in CareCloud in the 3rd quarter worth about $47,000. American Century Companies Inc. bought a new position in CareCloud in the 2nd quarter worth about $78,000. Man Group plc purchased a new position in CareCloud during the 4th quarter valued at about $84,000. Finally, Qube Research & Technologies Ltd purchased a new position in CareCloud during the 3rd quarter valued at about $87,000. 10.16% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of CareCloud in a report on Wednesday, June 24th. Wall Street Zen downgraded shares of CareCloud from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $3.25.

CareCloud Company Profile

CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.